衰老生物标志物CKAP4和PTX3分层重症病患者
Sean McCallion1, Thomas McLarnon1, Eamonn Cooper1
1Personalised Medicine Centre, School of Medicine, Ulster University, Londonderry BT48 7JL, UK.
Cells
|October 15, 2024
概括
细胞衰老蛋白CKAP4和PTX3在急性损伤 (AKI) 和慢性病 (CKD) 患者中升高. 这些发现表明CKAP4可能作为病进展的预后生物标志物.
科学领域:
- 老年学是一门学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
背景情况:
- 细胞衰老,一种不可逆转的生长停止,与衰老和慢性疾病有关.
- 它在急性损伤 (AKI) 和慢性病 (CKD) 中的作用尚不清楚,尽管怀疑高衰老.
- AKI和CKD患者表现出加速衰老的迹象.
研究的目的:
- 在AKI和CKD患者中确定关键的衰老生物标志物.
- 将病患者的衰老标记与其他慢性衰老疾病的对照进行比较.
- 为了利用OLINK蛋白质组学来发现生物标志物.
主要方法:
- 采用了OLINK蛋白质组技术.
- 分析了AKI和CKD患者的蛋白质表达.
- 结果与患有慢性衰老疾病的对照组进行了比较.
主要成果:
- 在AKI和CKD患者中,CKAP4和PTX3蛋白显著上调 (p < 0.0001).
- 这些上调的蛋白质表明它们在病的发病过程中起着作用.
- 与对照组相比,CKAP4在AKI和CKD中表现不同.
结论:
- 在病中,CKAP4和PTX3是关键的衰老生物标志物.
- CKAP4可以作为AKI和CKD的预后生物标志物.
- 需要进一步的研究来阐明这些蛋白质在病发展中的作用.
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
2
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
2
Chronic Kidney Disease I: Introduction
2
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
2
Acute Kidney Injury IV: Diagnostic Studies and Prevention
2
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
2
Acute Kidney Injury III: Clinical Manifestations
2
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
2
Factors Affecting Renal Clearance: Renal Impairment
59
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
59
Chronic Kidney Disease II: Clinical Manifestations
2
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
2


